| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.1 | 0.07 |